ARCHIVES

Avastin-Zybrestat Combination Increases Progression-Free Survival in Phase II Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

Clinical Research Programs Could Be Accredited, IOM Says.

April 20, 2001

Health Groups Urge FDA To Regulate Tobacco Products, Including E-Cigarettes

September 5, 2014

Harold Rusch, McArdle Gounder, Dies At 79

June 3, 1988

First-Line Bendamustine Doubles PFS In Non-Hodgkin and Mantle Cell Lymphoma

February 22, 2013

NCI Formaldehyde Finding Criticized

March 7, 1986

Health Care Reform: Fundamental changes Ahead For Cancer Research And Care

October 8, 1993